d1e30690_dic_NECT___Inclusion_completed__Cancer_type
[Title] A Safety and Efficacy Study of Adding Low Dose Pegylated IFN-alpha 2B to Standard Dose Dasatinib in Patients With Newly Diagnosed Chronic Phase Myeloid Leukemia [Country] NO [Cancer type] 
Leukemia
Nordic NECT - Inclusion completed
Cancer type